Monday, July 9, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Savient Pharmaceuticals Announces CEO Appointment and Reorganization ...
MarketWatch (press release)
EAST BRUNSWICK, N.J., July 9, 2012 /PRNewswire via COMTEX/ -- Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the Company's Board of Directors has appointed Louis Ferrari, Executive Vice President, President North American ...
See all stories on this topic »
FMCG, pharmaceuticals safe bets: M Oswal
Moneycontrol.com
Shubham Agarwal of Motilal Oswal Securities is of the view that FMCG and pharmaceuticals are safe bets.
See all stories on this topic »
Lupin Pharmaceuticals Inc's CEO Vinita Gupta is the Entrepreneur of the Year ...
Equity Bulls
Lupin Pharmaceuticals Inc's CEO Vinita Gupta is the Entrepreneur of the Year 2012 Award winner in Maryland.
See all stories on this topic »
Tonix Pharmaceuticals Reports Positive Preclinical Data on Sublingual TNX-102
MarketWatch (press release)
NEW YORK, Jul 09, 2012 (BUSINESS WIRE) -- Tonix Pharmaceuticals Holding Corp. (OBB:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing non-addictive treatments for chronic pain syndromes, including fibromyalgia ...
See all stories on this topic »
Collegium Pharmaceutical Expands its Management Team to Support ...
MarketWatch (press release)
CUMBERLAND, R.I., Jul 09, 2012 (BUSINESS WIRE) -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, is pleased to announce the addition of three key members to ...
See all stories on this topic »
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global ...
MarketWatch (press release)
SOUTH SAN FRANCISCO, Calif., July 9, 2012 /PRNewswire via COMTEX/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it has appointed John E. Osborn as Senior Vice President, Global Corporate Affairs. In his role, Mr. Osborn will ...
See all stories on this topic »
Par Pharmaceutical Companies to Report Second Quarter 2012 Results on ...
Sacramento Bee
PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Thursday, August 2, 2012 at 9:00 AM EDT to review results for the second quarter 2012. The Company will release its ...
See all stories on this topic »
Lupin CEO bags Entrepreneur Of The Year Award: Ernst & Young
Business Standard
Ernst & Young LLP today announced that Ms. Vinita Gupta, CEO of Lupin Pharmaceuticals Inc., received the Ernst & Young Entrepreneur Of The Year®2012Award in the Health Services and Technology category in Maryland. The award recognizes ...
See all stories on this topic »
ACETO Subsidiary, Rising Pharmaceuticals, Launches Generic Version of Soma ...
MarketWatch (press release)
PORT WASHINGTON, N.Y., Jul 9, 2012 (GlobeNewswire via COMTEX) -- ACETO Corporation (NASDAQ:ACET) , a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generics, ...
See all stories on this topic »
Less regulatory pressures, more growth: say top pharma execs
In-PharmaTechnologist.com
In the 2012 pharmaceutical outlook survey, the USA audit, tax and advisory firm asked head honchos which initiative they would spend most time on this year. Both regulatory changes and investment in organic growth ranked the top time takers. Over 60 ...
See all stories on this topic »

In-PharmaTechnologist.com


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost